Intuitive Surgical (NASDAQ:ISRG) announced its quarterly earnings results on Thursday. The medical equipment provider reported $2.77 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.62 by $1.15, MarketWatch Earnings reports. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $966.81 million. Intuitive Surgical had a return on equity of 13.62% and a net margin of 26.07%. Intuitive Surgical’s revenue for the quarter was down 4.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.60 EPS.
Shares of NASDAQ:ISRG opened at $752.68 on Friday. The firm has a market cap of $88.08 billion, a price-to-earnings ratio of 79.15, a PEG ratio of 14.13 and a beta of 0.94. Intuitive Surgical has a 12-month low of $360.50 and a 12-month high of $778.83. The stock’s 50-day moving average price is $708.30 and its two-hundred day moving average price is $613.19.
A number of brokerages have issued reports on ISRG. Sanford C. Bernstein lifted their price target on Intuitive Surgical from $625.00 to $725.00 and gave the stock an “outperform” rating in a report on Monday, July 20th. Bank of America downgraded Intuitive Surgical from a “buy” rating to a “neutral” rating and lifted their price target for the stock from $725.00 to $760.00 in a report on Tuesday, September 8th. UBS Group lifted their price target on Intuitive Surgical from $565.00 to $670.00 and gave the stock a “neutral” rating in a report on Wednesday, July 22nd. Raymond James lifted their target price on Intuitive Surgical from $725.00 to $800.00 and gave the stock an “outperform” rating in a research report on Monday, October 12th. Finally, Robert W. Baird initiated coverage on Intuitive Surgical in a research report on Tuesday, September 1st. They issued a “neutral” rating and a $700.00 price target on the stock. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Intuitive Surgical has a consensus rating of “Hold” and a consensus price target of $708.36.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Story: What causes a yield curve to invert?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.